Loading, please wait...
.webp&w=384&q=75){kind=logo}
Verifying...
Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
— Hippocrates
Merck Healthcare R&D India recently signed a Memorandum of Understanding (MoU) with the Manipal Academy of Higher Education (MAHE). This partnership aims to cultivate high-quality healthcare R&D talent by bridging the gap between academic learning and industry needs. Furthermore, the collaboration will provide students with the practical skills required to succeed in a real-world research environment. Consequently, this initiative helps build a future-ready workforce for the Indian healthcare sector.
The centerpiece of this collaboration is the launch of the Catalyst Program at MAHE. This initiative offers a structured three-month training curriculum. Merck professionals will lead expert sessions, providing hands-on learning and deep domain insights. Therefore, students will gain exposure to critical fields like pharmacovigilance and regulatory affairs. Additionally, the program leverages MAHE\'s interdisciplinary strengths across life sciences and health domains to maximize impact.
Suneela Thatte, Vice President of Merck Healthcare R&D India, emphasized the importance of this link. She noted that academic excellence must align with industry relevance to prepare students for professional careers. Moreover, Merck has already seen positive results from similar partnerships with JSS Academy and Dayananda Sagar University. This move reinforces Merck\'s commitment to building a sustainable pipeline of researchers in India. The program ultimately seeks to empower students with global standard expertise.
Q1: What is the primary objective of the Catalyst Program?
The Catalyst Program aims to bridge the gap between classroom learning and industry requirements. It equips students with practical skills and hands-on exposure to real-world R&D environments.
Q2: How long is the training duration for students?
The program is a structured three-month initiative led by professionals from Merck Healthcare R&D India.
Q3: Which academic domains does the program draw upon?
The initiative utilizes MAHE’s interdisciplinary strengths in health sciences, life sciences, and various allied domains to provide a comprehensive learning experience.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Link will be sent via SMS to your number.
Merck India and MAHE launch the Catalyst Program, a three-month training initiative designed to bridge the gap in healthcare R&D talent and industry skills....
last month
A large individual patient data meta-analysis identifies 4.0-5.0 mmol/L as the optimal serum potassium range for both HFrEF and HFpEF patients....
Today
A study in rural Kenya shows that trained peer mothers can significantly improve breastfeeding support and bonding for mothers of low birthweight infants....
Today
Study confirms EP-guided surgical ablation during PVR reduces post-op VT inducibility and long-term SCD risk in adults with repaired Tetralogy of Fallot....
Today
A new study demonstrates how interpretable machine learning models can predict mycetoma outcomes, helping clinicians identify high-risk patients earlier....
Today
A study of 4,695 Chinese seniors shows how low testosterone in men and high FSH in women increase sarcopenia risk, while high testosterone protects women....
Today